CIDRAP newsletters options
Interviews with clinicians at hospitals in three low- and middle-income countries highlight some of the barriers to appropriate antibiotic prescribing in these settings, according to a study published yesterday in Antimicrobial Resistance & Infection Control.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Researchers reporting on two non-peer–reviewed studies published this week on the preprint server medRxiv followed up months after adults' COVID-19 hospitalization and found that 55% to 71% have not fully recovered. Middle age and female sex were associated with a higher likelihood of worse recovery in both studies.
Brazil's deaths crossed the 300,000 mark, the only country besides the United States to pass that number.
Experts say aerosols, the B117 variant, classroom density, and lunchtime all play a role.
Today is Biden’s 65th day in office; his 100th will be on Apr 30.
Patients given the antiviral drug improved in 5 days, compared with 7 days in the control group.
Since the introduction of the human papillomavirus (HPV) vaccine in 2006, rates of HPV infections among females fell 88% in teens 14 to 19 years and by 81% in those aged 20 to 24 by 2018, according to a study today in Morbidity and Mortality Weekly Report (MMWR).
SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth, according to a study published today in Nature Medicine. This could change perceptions on how the virus travels to the lungs or the digestive system as well as how it is transmitted from person to person, the researchers write.
The rise is led by cases in the Americas and Europe, with deaths leveling off after a 6-week drop.
Researchers describe infection rates in a real-world scenario amid a surge of infections.
The B117 variant accounted for most viruses in one Minnesota sampling.
Until COVID, TB was the world's top infectious cause of death, and the pandemic threatens to derail efforts to curtail it.
Remdesivir treatment of hospitalized patients with noncritical COVID-19 is associated with better clinical improvement, shorter recovery and hospital stays, and safety, according to a meta-analysis of five randomized clinical trials published today in the Journal of Antimicrobial Chemotherapy. No significant association was found in regards to mortality.
"Interdisciplinary cooperation is needed for comprehensive care of these patients."
The NIAID says the company may have included outdated data from a clinical trial.
Parts of Peru and Paraguay are also reporting pressure on ICUs, with Venezuela and Uruguay reporting surges.
People with COVID-19 infections who also used the inflammatory bowel disease (IBD) drug infliximab had significantly fewer detectable antibodies than those who used vedolizumab, which treats IBD without the immune suppression, according to a study yesterday in Gut.
Audit and feedback with peer comparison was associated with small reductions in prolonged antibiotic treatment in a study involving physicians and long-term care (LTC) facility residents in Ontario, Canadian researchers reported today in Clinical Infectious Diseases.
"We can look at the surge that happened in Europe, and we do not want that to happen."
